Michal, Matthias
Schulz, Andreas
Wild, Philipp S.
Koeck, Thomas
Münzel, Thomas
Schuster, Alexander K.
Strauch, Konstantin
Lackner, Karl
Süssmuth, Sigurd D.
Niessen, Heiko G.
Borta, Andreas
Allers, Kelly A.
Zahn, Daniela
Beutel, Manfred E.
Funding for this research was provided by:
Government of Rhineland-Palatinate (Z 961-386261/733, Z 961-386261/733)
Federal Ministry of Education and Research (BMBF 01EO1503, BMBF 01EO1503)
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
Article History
Received: 12 August 2022
Accepted: 3 January 2023
First Online: 11 January 2023
Declarations
:
: The study protocol and study documents were approved by the local ethics committee of the Medical Chamber of Rhineland-Palatinate, Germany (reference no. 837.020.07; original vote: 22.3.2007, latest update: 20.10.2015) and by the local and federal data safety commissioners. Informed consent was obtained written by all participants of the GHS. The study was carried out in accordance with relevant guidelines and regulations.
: Not applicable.
: MM, PSW, AKS, TM, AS, KS, KL, AB, TK, DZ, and MEB declare no competing interests. SDS is a full-time employee of Boehringer Ingelheim International GmbH, but reports no conflicts of interest with regard to this study. KAA and HGN are full-time employees of Boehringer Ingelheim Pharma GmbH & Co. KG and report no conflicts of interest with regard to this study.